Leadership Driving Scientific Rigor
and Operational Excellence
At Sortis Pharma, our management team brings decades of multidisciplinary experience in pharmaceutical research,
formulation development, analytical sciences, and regulatory strategy. Their leadership ensures disciplined
pharmaceutical development, quality systems, and global operations.
Dr. Sandeep Kumar Nadendla
Dr. Sandeep Kumar Nadendla is the Founder, CSO and Chief Executive Officer of Ipseity Group of companies which includes- SORTIS Pharma Healthcare, Hyderabad, Ipseity LLC, USA, Maverics LLC, USA, Ipseity Agri Biotech, Ipseity Diagnostics, Guntur, India and Ipseity Accounting and Consultancy, bringing over 18 years of multidisciplinary expertise at the intersection of biotechnology, molecular oncology, and pharmaceutical innovation.
A passionate scientist and seasoned business leader, Dr. Nadendla drives the company’s vision, leads strategic initiatives, oversees R&D direction, and fosters innovation across all verticals of Ipseity Group of companies. Prior to founding Ipseity, Dr. Nadendla held key leadership roles in both academia and industry. He served as Head of the department molecular pathology Ipseity Diagnostics, USA and Elite Clinical Laboratory, USA, Director of Clinical Development at DxGenesis Healthcare Pvt. Ltd., where he was instrumental in advancing clinical strategies and therapeutic programs.
His earlier research tenure includes a Postdoctoral Scientist position at the French Alternative Energies and Atomic Energy Commission (CEA), where he contributed to critical cancer research, focusing on molecular pathways and therapeutic targets. Currently, ipseity is enhancing research in the micro and molecular biological research through collaborations.
An innovative biotechnology engineer and prolific researcher, Dr. Nadendla has authored numerous publications, particularly in the areas of prostate cancer and epidermal keratinocytes. His deep scientific insight, combined with strong organizational and interpersonal skills, positions him as a visionary leader in the life sciences and pharmaceutical sectors.
Apart from Sortis Pharma, Dr. Nadendla is also the founder and CEO & CSO for:
- Ipseity, LLC- USA
- Maverics, LLC- USA
- Ipseity Bio Pvt Ltd- India
- Ipseity Diagnostics & Research- India
- Surequest Diagnostics, LLC- USA
- Ipseity Agri Biotech Pvt Ltd.
- Ipseity Accounting and Consulting Pvt Ltd, India
- Genelinx IT Consultants, Dubai, UAE
Our R&D team
S Rajesh Prusti
Rajesh Prusti has more than 17 years of extensive experience in formulation research and development across global pharmaceutical organizations. As a Director of R&D at SORTIS Pharma, he is responsible for driving scientific strategies and overseeing Preformulation, formulation development, analytical development, and end-to-end project delivery. His deep technical acumen and cross-functional leadership play a key role in advancing SORTIS’s innovative drug development pipeline.
Before joining SORTIS, Rajesh held progressive roles in both international and Indian pharmaceutical firms. He served as Technical Lead at Saidal Groupe Ltd., Algeria, where he led formulation development and technology transfer initiatives. Subsequently, he contributed to several complex formulations at Aizant Drug Research Solutions, Shilpa Medicare Limited, Aragen Life Sciences (formerly GVK Biosciences), and the Himalaya Drug Company. Across these roles, he consistently delivered on formulation strategies for a range of dosage forms including NCEs and differentiated or 505(b)(2) NDA’s.
Rajesh holds a Master's degree in Pharmaceutical Technology from the School of Pharmaceutical Education and Research (SPER), Berhampur University, India. His comprehensive experience and strategic mindset make him a key member of the leadership team, driving innovation and quality in SORTIS Pharma’s R&D efforts.
Ramakrishna Saketi
Mr. Ramakrishna brings over 12 years of specialized experience in preformulation and formulation development of oral solid dosage forms (OSD), semi-solids or topicals. At SORTIS Pharma, he leads formulation strategy, team management, and end-to-end development activities for NCEs, generics, 505(b)(2) products. He has a strong command over complex dosage forms including bilayer tablets, pellets, veterinary formulations and a range of release profiles such as IR, ER, SR, MR, and CR. His work spans across therapeutic areas including oncology, hormonal, and high-potency drugs, with a deep understanding of regulatory pathways and compliance.
Prior to SORTIS, he held key roles at Dr. Reddy’s Laboratories – IPDO, Aragen Life Sciences, Aizant Drug Research Solutions, and Shilpa Medicare Ltd. He has been actively involved in clinical, pilot, pivotal, and commercial batch executions with global partners and has participated in various regulatory audits.
Ramakrishna holds a Master’s degree in Pharmaceutics from Jawaharlal Nehru Technological University and is recognized for his strong technical foundation and regulatory expertise across the product development lifecycle.
Shiva Kumar Jagirdaar
Mr. Shiva Kumar brings over 15 years of experience in pharmaceutical analytical research and development, specializing in solid oral dosage forms and injectable formulations. He has strong expertise in pre-formulation and analysis of New Chemical Entities (NCEs), generics, and 505(b)(2) products.
His core competencies include analytical method development, method validation, method transfer, lifecycle management, and implementation of Quality Management Systems (QMS). His comprehensive understanding of analytical strategies plays a critical role in successful product development, regulatory submissions, and technology transfer activities.
Prior to joining Sortis, Mr. Shiva Kumar has held key positions at reputed pharmaceutical organizations including Dr. Reddy’s Laboratories, Apotex Research Private Limited, Fresenius Kabi Limited, Asymchem Laboratories (Tianjin) Co., Ltd. Through these roles, he has developed strong expertise in end-to-end product development operations for highly regulated markets.
Mr. Shiva Kumar holds a Master’s degree in Pharmaceutical Analysis & Quality Assurance from Jawaharlal Nehru Technological University. He has also completed an Executive Program in Business Analytics and Intelligence from Indian Institute of Management Rohtak, strengthening his ability to integrate analytical science with data-driven decision-making and strategic business insights.
Leadership Philosophy
Our management team at Sortis Pharma integrates scientific expertise with structured quality systems and regulatory understanding to support consistent operations across development, manufacturing readiness, and global supply. Their oversight fosters a culture of discipline, transparency, and continuous improvement.
Looking for a Trusted Pharmaceutical Partner?
Let’s discuss how our pharmaceutical capabilities can support your requirements.